0001209191-15-032248.txt : 20150403 0001209191-15-032248.hdr.sgml : 20150403 20150403160913 ACCESSION NUMBER: 0001209191-15-032248 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150401 FILED AS OF DATE: 20150403 DATE AS OF CHANGE: 20150403 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celladon Corp CENTRAL INDEX KEY: 0001305253 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330971591 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11988 EL CAMINO REAL STREET 2: SUITE 650 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-366-4288 MAIL ADDRESS: STREET 1: 11988 EL CAMINO REAL STREET 2: SUITE 650 CITY: SAN DIEGO STATE: CA ZIP: 92130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TAKEYA RYAN K CENTRAL INDEX KEY: 0001590702 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36183 FILM NUMBER: 15751379 MAIL ADDRESS: STREET 1: C/O CELLADON CORPORATION STREET 2: 12760 HIGH BLUFF DRIVE, SUITE 240 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-04-01 0 0001305253 Celladon Corp CLDN 0001590702 TAKEYA RYAN K 11988 EL CAMINO REAL STE. 650 SAN DIEGO CA 92130 0 1 0 0 VP, Manufacturing Common Stock 2015-04-01 4 M 0 4444 1.12 A 5876 D Common Stock 2015-04-01 4 S 0 4444 19.13 D 1432 D Stock option (right to buy) 1.12 2015-04-01 4 M 0 4444 0.00 D 2013-01-27 2022-06-14 Common Stock 4444 139574 D The amount includes shares purchased under Celladon Corporation's employee stock purchase plan prior to the reported transaction. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 15, 2014. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.84 to $19.36 per share, inclusive. The reporting person undertakes to provide to Celladon Corporation, any security holder of Celladon Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. 25% of the shares subject to the option vested and became exercisable on the one year anniversary of January 27, 2012 (the "Vesting Commencement Date"), and 1/48th of the shares vest in equal monthly installments thereafter, over the remaining three years. /s/ Rebecque J. Laba, Attorney-in-Fact 2015-04-03